These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1100310)

  • 21. In vivo study of platelet aggregation in rats.
    Pinon JF
    J Pharmacol Methods; 1984 Sep; 12(2):79-84. PubMed ID: 6536819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
    Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG
    Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action in vitro of isoxsurprine on platelet aggregation induced by ADP, adrenaline and collagen].
    Di Perri T; Forconi S; Vittoria A; Laghi Pasini F; De Gori V
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1385-90. PubMed ID: 4458727
    [No Abstract]   [Full Text] [Related]  

  • 25. Suloctidil: a novel inhibitor of platelet aggregation in human beings.
    de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G
    Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects on platelet aggregation of oral prostaglandin E2 used for the induction of labour.
    Myatt L; Elder MG
    Br J Obstet Gynaecol; 1975 Jun; 82(6):449-52. PubMed ID: 1138835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Action of ethacrynic acid on vitro in platelet aggregation induced by ADP, adrenaline or collagen].
    Vittoria A; Laghi Pasini F; De Gori V; Forconi S; Di Perri T
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1397-42. PubMed ID: 4458729
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of furosemide on vitro in platelet aggregation by ADP, adrenaline or collagen].
    Vittoria A; Laghi Pasini F; De Gori V; Forconi S; Di Perri T
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1391-6. PubMed ID: 4458728
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.
    Michal F; Motamed M
    Br J Pharmacol; 1975 Jun; 54(2):221P-222P. PubMed ID: 1148513
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of increasing doses of aspirin on platelet aggregation among stroke patients.
    Gan R; Teleg RA; Florento L; Bitanga ES
    Cerebrovasc Dis; 2002; 14(3-4):252-5. PubMed ID: 12403959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term ticlopidine treatment on platelet function and its tolerability in cerebrovascular disease.
    Carrieri P; Orefice G; Fioretti A; Indaco A; Carfagna S
    J Int Med Res; 1984; 12(5):286-91. PubMed ID: 6500168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of nifedipine, a calcium antagonist, on platelet function.
    Dale J; Landmark KH; Myhre E
    Am Heart J; 1983 Jan; 105(1):103-5. PubMed ID: 6849223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of rabbit platelet function on simultaneous administration of ticlopidine hydrochloride and OKY-046.
    Kosugi T; Nakamura M; Saitoh S; Kinjoh K
    Int J Tissue React; 1991; 13(3):123-9. PubMed ID: 1960013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis.
    Kirstein P; Jogestrand T; Johnsson H; Olsson AG
    Atherosclerosis; 1980 Aug; 36(4):471-80. PubMed ID: 7417366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.